<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9F83FD31-5C58-4A50-8F95-F016830D1F58"><gtr:id>9F83FD31-5C58-4A50-8F95-F016830D1F58</gtr:id><gtr:name>McGill University Health Center</gtr:name><gtr:address><gtr:line1>McGill University Health Center</gtr:line1><gtr:line2>3640 University Street</gtr:line2><gtr:postCode>H3A 2B2</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A919B771-5C0F-4AD1-B747-03D25677DC3B"><gtr:id>A919B771-5C0F-4AD1-B747-03D25677DC3B</gtr:id><gtr:name>University of Texas Southwestern Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D317E8C1-3E16-4E48-8AAC-E2A0961F5299"><gtr:id>D317E8C1-3E16-4E48-8AAC-E2A0961F5299</gtr:id><gtr:name>Erasmus University Medical Center</gtr:name><gtr:address><gtr:line1>PO Box 2040</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9A22541F-DA58-481E-8D0C-C4BCF4EA030E"><gtr:id>9A22541F-DA58-481E-8D0C-C4BCF4EA030E</gtr:id><gtr:name>EMBL - European Bioinformatics Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB10 1SD</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/7369E051-ECFC-4808-A044-651879C318D1"><gtr:id>7369E051-ECFC-4808-A044-651879C318D1</gtr:id><gtr:name>MRC Cancer Cell Unit</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB2 2XZ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7369E051-ECFC-4808-A044-651879C318D1"><gtr:id>7369E051-ECFC-4808-A044-651879C318D1</gtr:id><gtr:name>MRC Cancer Cell Unit</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB2 2XZ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9F83FD31-5C58-4A50-8F95-F016830D1F58"><gtr:id>9F83FD31-5C58-4A50-8F95-F016830D1F58</gtr:id><gtr:name>McGill University Health Center</gtr:name><gtr:address><gtr:line1>McGill University Health Center</gtr:line1><gtr:line2>3640 University Street</gtr:line2><gtr:postCode>H3A 2B2</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A919B771-5C0F-4AD1-B747-03D25677DC3B"><gtr:id>A919B771-5C0F-4AD1-B747-03D25677DC3B</gtr:id><gtr:name>University of Texas Southwestern Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D317E8C1-3E16-4E48-8AAC-E2A0961F5299"><gtr:id>D317E8C1-3E16-4E48-8AAC-E2A0961F5299</gtr:id><gtr:name>Erasmus University Medical Center</gtr:name><gtr:address><gtr:line1>PO Box 2040</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9A22541F-DA58-481E-8D0C-C4BCF4EA030E"><gtr:id>9A22541F-DA58-481E-8D0C-C4BCF4EA030E</gtr:id><gtr:name>EMBL - European Bioinformatics Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB10 1SD</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9A125B10-2A83-4B24-B5F6-DF68D52D9381"><gtr:id>9A125B10-2A83-4B24-B5F6-DF68D52D9381</gtr:id><gtr:firstName>Matthew Jonathan</gtr:firstName><gtr:surname>Murray</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_EX_G0800464"><gtr:id>533B625F-E469-4692-BF43-51FD1843857B</gtr:id><gtr:title>The role of microRNAs in paediatric malignant germ cell tumours (MGCTs) and germ cell development</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>MC_EX_G0800464</gtr:grantReference><gtr:abstractText>Aims: To investigate the role of tiny genetic regulators (microRNAs) in childhood malignant germ cell tumours (MGCTs) to improve management of such cancers. 

Research Proposal: MGCTs come from egg- or sperm-producing cells, representing 4% of childhood cancers. They occur in testes/ovaries (gonadal) and other body sites (extragonadal). There are different types, depending on tumour cell appearance under the microscope, although all are treated identically. Compared with other paediatric tumours, very little is known regarding factors that affect outcome in MGCTs. Studies of genetic changes in tumours may give an indication of the likely response to treatment. We have analysed expression of tiny fragments of genetic code called microRNA in MGCT samples. MicroRNAs act as cancer-forming genes by regulating other genetic code (messenger RNA) which produce proteins that control cell growth/vital functions. 

Prospective outcomes: Include identification of common/distinct patterns of microRNA expression between different MGCTs; correlation of these profiles with other MGCT genetic changes and clinical features; comparison with microRNA profiles in adult MGCTs; studying effects of altering microRNA levels in model systems. 

Expected benefits: Our findings may allow identification of 'biomarkers' used to help diagnosis and predict outcome in MGCTs as well as suggesting potential targets for new drug treatments.</gtr:abstractText><gtr:technicalSummary>Aims/objectives: By studying the role of microRNAs in paediatric malignant germ cell tumours (MGCTs) and germ cell development we aim to 1) identify diagnostic tools/prognostic markers 2) suggest targets for the generation of novel therapeutic agents and 3) identify microRNAs that play an important role in vertebrate development.

Background: Paediatric MGCTs occur at several different anatomical sites and are heterogeneous in nature. There are a number of different histological subtypes, but despite this, treatment is almost identical for all cases. They represent 4% of cancers in childhood, but their incidence is increasing and, furthermore, testicular MGCTs are a leading cause of death in young men. Our understanding of MGCT biology lags significantly behind other paediatric solid tumours and leukaemias. MicroRNAs (miRNAs) are short, non protein-coding RNAs that act post-transcriptionally as regulators of gene expression. miRNAs act as oncogenes and tumour suppressor genes in their own right and are reported to be diagnostic and prognostic markers in certain cancers. We propose to study these novel gene regulators in this under-investigated paediatric cancer group.

Design/methodology: Using Exiqon microarray technology we have performed global expression profiling for 585 known human miRNAs, using the UK national collection of paediatric MGCTs as well as control tissues and cell lines. Unsupervised analysis, determined by the expression of 275 miRNAs, demonstrated clustering largely by histological subtype. Supervised clustering analysis identified 127 known miRNAs most differentially expressed between histological subtypes, controls and cell lines (p&amp;lt;0.0001). Current validation of this data using Taqman quantitative real time PCR (qRT-PCR) and in-situ hybridisation (ISH) is in progress. We will further investigate common/distinct patterns of miRNA expression between different subtypes of MGCT and between adult and childhood disease, exploiting the extensive clinical and follow-up data that is available. We will relate these profiles to genomic changes and protein-coding gene expression profiles in the same samples. We will independently validate our findings on separate MGCT samples/tissue microarray. Using bioinformatics (e.g. miRBase) we will identify candidate miRNAs that act as oncogenes or tumour suppressor genes via direct negative regulation of protein-coding genes involved in the pathogenesis of MGCTs. 

Scientific opportunities will arise from functional studies looking at the biological effects of over-expression/depletion of these miRNAs in MGCT cell lines. Collaboration on a Xenopus model will allow study of microRNA expression during vertebrate development. 

Medical opportunities will arise from identification of key miRNAs that can be used diagnostically and prognostically as clinical tools.</gtr:technicalSummary><gtr:fund><gtr:end>2011-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>0</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Erasmus University Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Longitudinal monitoring of serum microRNAs in malignant germ cell tumours</gtr:description><gtr:id>9F69E869-8217-48D3-8949-70654BBA2D7D</gtr:id><gtr:impact>Work will result in manuscript for submission for publication</gtr:impact><gtr:outcomeId>JhamY1ssdQK-1</gtr:outcomeId><gtr:partnerContribution>Performing qRT-PCR</gtr:partnerContribution><gtr:piContribution>Methodology, provision of samples, analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Texas Southwestern Medical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Identification of prognostic gene signatures in malignant germ cell tumours</gtr:description><gtr:id>10DD7933-F507-4A7F-AA23-DCE0A8C7BE60</gtr:id><gtr:impact>No outputs/outcomes as yet</gtr:impact><gtr:outcomeId>FdwSWFMqBNo-1</gtr:outcomeId><gtr:partnerContribution>Collaborative project and grant applications</gtr:partnerContribution><gtr:piContribution>Collaborative project and grant applications</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Astra Zeneca blood-based microRNA project</gtr:description><gtr:id>FE5C53F9-ECD3-45FE-96AE-BB38F018C89B</gtr:id><gtr:impact>Just commenced in September 2014</gtr:impact><gtr:outcomeId>545b92ca8241e3.48425097-1</gtr:outcomeId><gtr:partnerContribution>Post-doctoral scientist and consumables for minimum two year period, 2014-2016.</gtr:partnerContribution><gtr:piContribution>Working together to establish blood-based microRNA testing for patients with malignant germ cell tumours - infrastructure, lab skills and knowledge</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>McGill University Health Centre</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:department>Department of Medical Genetics</gtr:department><gtr:description>DICER1-mutated PPB associated serum microRNAs</gtr:description><gtr:id>AA0B56D1-0DD3-405F-B2CE-668602E243A8</gtr:id><gtr:impact>Manuscript submitted for publication</gtr:impact><gtr:outcomeId>p2AHfkzWLqw-1</gtr:outcomeId><gtr:partnerContribution>DICER1 somatic mutational analysis of the pleuro-pulmonary blastoma tumour tissue</gtr:partnerContribution><gtr:piContribution>Ethical approval, sample collection, qRT-PCR analysis, interpretation, manuscript writing.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Erasmus University Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Diagnostic serum microRNAs in malignant germ cell tumours</gtr:description><gtr:id>F5462672-A1D5-4B97-AF98-87A486BA827C</gtr:id><gtr:impact>Collaborative manuscript published in Molecular Oncology 2013</gtr:impact><gtr:outcomeId>b4zvxRkrd2o-1</gtr:outcomeId><gtr:partnerContribution>Refinement of scientific method, provision of samples, data interpretation and analysis</gtr:partnerContribution><gtr:piContribution>Provision of samples, data interpretation and analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>EMBL European Bioinformatics Institute (EMBL - EBI)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration, EMBL-EBI, Hinxton, Cambridge, UK</gtr:description><gtr:id>D3290658-26E6-4FE8-9D4A-EEF0211ABF7D</gtr:id><gtr:impact>Outputs include accepted abstracts for poster and oral presentation at national and international meetings, as well as publications in peer reviewed journals (Cancer Research, Molecular Cancer).</gtr:impact><gtr:outcomeId>KkdG3J56mxy-1</gtr:outcomeId><gtr:partnerContribution>Bioinformatic support for processing mRNA and miRNA microarray data, next generation sequencing data etc

Use of novel bioinformatic tools to integrate mRNA and miRNA datasets</gtr:partnerContribution><gtr:piContribution>Provide raw microarray and next generation sequencing data for analysis, validate results using qRT-PCR etc, jointly analyse results.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>McGill University Health Centre</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:department>Department of Medical Genetics</gtr:department><gtr:description>DICER1 mutations in germ cell tumours</gtr:description><gtr:id>8345A027-3388-4990-ABC9-699A8BC948CA</gtr:id><gtr:impact>Two publications thus far - Witkowski J Pathol 2013 and Witkowski BJC 2013</gtr:impact><gtr:outcomeId>tFwKUDF1Kpo-1</gtr:outcomeId><gtr:partnerContribution>Processing of samples</gtr:partnerContribution><gtr:piContribution>Provision of samples, expertise and manuscript preparation/revision</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>University of Cambridge Press Release - LIN28/let-7 axis in germ cell tumours</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>27D00B08-0AE4-4124-A87C-109169E9F22E</gtr:id><gtr:impact>Interest from media and reported in national press, August 2013

Increased correspondence from patient groups and other health care professionals re the potential for targetting this pathway therapeutically</gtr:impact><gtr:outcomeId>545be29c524863.68744270</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.cam.ac.uk/research/news/scientists-discover-a-molecular-switch-in-cancers-of-the-testis-and-ovary</gtr:url></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NCRI/CRUK press release for serum microRNA work in childhood tumours</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>38C49A5C-9DBE-4684-9FB7-BF0ACA84FD27</gtr:id><gtr:impact>Much interest from research and clinical colleagues re this methodology</gtr:impact><gtr:outcomeId>545baa33c4f1b2.93042397</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.cancerresearchuk.org/about-us/cancer-news/press-release/2014-11-01-cancer-cell-fingerprints-in-the-blood-may-speed-up-childhood-cancer-diagnosis</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Week, Cambridge, UK</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>BAA7D7E3-0868-4687-B181-1599F855414A</gtr:id><gtr:impact>Explained posters to adults, encouraged children to play games designing anti-cancer drugs etc.

High level of interest from public and large numbers of people attended the workshop.</gtr:impact><gtr:outcomeId>RPgEyfP3mmM</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>eCancer TV interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3D3AFE8B-FC30-4085-922D-B54E53FD25C2</gtr:id><gtr:impact>Impact not yet known - recorded at NCRI conference November 2014

No impacts yet</gtr:impact><gtr:outcomeId>545be1b108b171.02895569</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lay research update talk at GOSHCC</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>EA9504CB-10D6-426B-8B0D-747D727390FA</gtr:id><gtr:impact>Talk resulted in interest from research supporters re potential impact of blood-based diagnosis and disease monitoring in children with cancer

Impact awaited</gtr:impact><gtr:outcomeId>545ba6ba0e64d4.25186282</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>149000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Targeting oncogenic microRNA clusters in malignant germ cell tumours using tiny locked nucleic acids</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Children with Cancer UK</gtr:fundingOrg><gtr:id>C15DAC33-841A-42FB-863F-D1B6DDCF81EC</gtr:id><gtr:outcomeId>545ba5579f89e3.98615956</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>55781</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Addenbrooke's Charitable Trust, Cambridge, UK</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Addenbrooke's Charitable Trust (ACT)</gtr:fundingOrg><gtr:id>66614FCA-703E-4E57-9C52-2DAB5EE9C937</gtr:id><gtr:outcomeId>dAbrMdk1Wqx0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>32611</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Isaac Newton Trust</gtr:department><gtr:description>Assessing the clinical utility of blood-based microRNAs for the management of malignant germ cell tumours</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>University of Cambridge</gtr:fundingOrg><gtr:id>7E0B143E-B539-414D-90CE-7086F7D69FF0</gtr:id><gtr:outcomeId>56cc365f24b4c9.18708148</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>26833</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>: 'A clinical dataset and tumour bank for malignant germ cell tumours in young people in the UK'</gtr:description><gtr:end>2014-11-02</gtr:end><gtr:fundingOrg>Laura Crane Youth Cancer Trust</gtr:fundingOrg><gtr:id>897F2E4B-6B9A-420C-A9AE-5E2E136BCA12</gtr:id><gtr:outcomeId>sx95baDHQVg</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>44087</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>'Novel genetic markers for blood-based diagnosis of common childhood cancers'</gtr:description><gtr:end>2013-05-02</gtr:end><gtr:fundingOrg>Sparks</gtr:fundingOrg><gtr:id>F63E4E78-8F9C-44A5-9D84-EBB69CAF0C64</gtr:id><gtr:outcomeId>aesHSUwsxxC</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Astra Zeneca blood-based microRNA project</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>AstraZeneca</gtr:fundingOrg><gtr:id>423377E9-2606-49CD-AA65-1311298583F4</gtr:id><gtr:outcomeId>545b94361ce187.52571079</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2300000</gtr:amountPounds><gtr:country>Unknown</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Improving Outcomes for Children and Young Adults with Extracranial Germ Cell Tumours</gtr:description><gtr:end>2021-01-02</gtr:end><gtr:fundingOrg>St. Baldrick's Foundation</gtr:fundingOrg><gtr:fundingRef>RG79925</gtr:fundingRef><gtr:id>766248E8-5E3E-46D4-9BF3-7B299A9A505A</gtr:id><gtr:outcomeId>56cc35fd0f7b81.26325094</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>49000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ACT-NIHR Cambridge BRC Cancer Research Training Fellowship</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>Addenbrooke's Charitable Trust (ACT)</gtr:fundingOrg><gtr:id>53719D33-2626-4C52-BF7F-7C5574A6F757</gtr:id><gtr:outcomeId>iKG7XChDPzi</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>99840</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>'Novel genetic markers for blood-based monitoring of treatment response in common childhood cancers'</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Children with Cancer UK</gtr:fundingOrg><gtr:id>3189CB5F-4C40-4590-8E25-384BFAAF3E8A</gtr:id><gtr:outcomeId>gDevazba1Ww</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>197895</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Targeting oncogenic microRNA clusters in malignant germ cell tumours using tiny locked nucleic acids</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>Action Medical Research</gtr:fundingOrg><gtr:id>E6ABE63D-D30E-439E-9B18-F104D53772CF</gtr:id><gtr:outcomeId>545ba4faeb08b8.24359607</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Experimental Cancer Medicine Centres (ECMC) Steering Group: Standardisation of analysis and reporting of circulating miRNAs by RTqPCR</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>7C3D2BC8-17D2-46D7-A277-B87BB3B65E3C</gtr:id><gtr:outcomeId>56cc38128b91c6.99373952</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of NCRI CCL GCT subgroup</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4CB3038F-13CE-4B1C-B7CD-ABD988EE1592</gtr:id><gtr:outcomeId>hjFHAvCnStL</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Demonstration of feasibility of detecting differential expression of microRNAs in serum from patients at diagnosis of malignant germ cell tumours</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>2250EA64-38D9-411E-950C-392264015E98</gtr:id><gtr:outcomeId>Tk9vEePT8mh</gtr:outcomeId><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MaGIC US UK GCT collaboration</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>F8F3FC90-7AC4-49AB-A268-BB653FFB80FD</gtr:id><gtr:outcomeId>Hyn9LuubX2m</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Collaborative prospective study of serum microRNAs in malignant GCT patients</gtr:description><gtr:id>8609C61E-3C5F-405C-9578-EF801A00050D</gtr:id><gtr:impact>Currently planning to embed within next phase of international clinical trials for patients with malignant GCTs via MaGIC collaboration.</gtr:impact><gtr:outcomeId>m4sRD2XZJa5</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Prospective study of serum microRNAs in malignant GCT patients</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>EpSSG group is planning new European prospective clinical trials of paediatric soft-tissue sarcoma. They wish to consider including diagnostic and disease-monitoring serum microRNAs in their study, and so have asked me to give a presentation at their meeting in Barcelona in December 2013.</gtr:description><gtr:id>1289AE75-9841-40FB-8CA4-CC4C6D00D3DE</gtr:id><gtr:impact>Impact awaited.</gtr:impact><gtr:outcomeId>hC6ChsCYZzP</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>EpSSG clinical trials</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours.

Murray MJ, Bell E, Raby KL, Rijlaarsdam MA, Gillis AJ, Looijenga LH, Brown H, Destenaves B, Nicholson JC, Coleman N.

Br J Cancer. 2016 Jan 19;114(2):151-62. doi: 10.1038/bjc.2015.429. Epub 2015 Dec 15.

PMID: 26671749</gtr:description><gtr:id>CA026E6B-B734-4513-A294-0E2EFDAB0E61</gtr:id><gtr:impact>New clinical trial established in 2016 (AGCT1531) testing this out</gtr:impact><gtr:outcomeId>56cc394431bf81.30657886</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Pipeline for analysing circualting microRNAs in malignant germ cell tumours</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Research method for detecting differentially expressed microRNAs in the serum in human patients with malignant germ cell tumours</gtr:description><gtr:id>96631C8B-5531-435B-B0BF-DB841AC42244</gtr:id><gtr:impact>From first description in 2011, four further publications have been published in this field (we are authors on three of the five papers) describing utility of this approach in robustly diagnosing these tumours</gtr:impact><gtr:outcomeId>VK5dGye8bHj</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Highly sensitive qRT-PCR detection method for serum microRNAs in malignant GCTs</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>6467C7A9-1B00-4C0C-BDFD-0E563000B6E7</gtr:id><gtr:title>Solid tumors of childhood display specific serum microRNA profiles.</gtr:title><gtr:parentPublicationTitle>Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98136b98a07f8ae33ef41569cbc66294"><gtr:id>98136b98a07f8ae33ef41569cbc66294</gtr:id><gtr:otherNames>Murray MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1055-9965</gtr:issn><gtr:outcomeId>56cc334bc67a73.14197816</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E82C9DA-2A9F-4E59-A4F1-85800BC37BBF</gtr:id><gtr:title>Serum levels of mature microRNAs in DICER1-mutated pleuropulmonary blastoma.</gtr:title><gtr:parentPublicationTitle>Oncogenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98136b98a07f8ae33ef41569cbc66294"><gtr:id>98136b98a07f8ae33ef41569cbc66294</gtr:id><gtr:otherNames>Murray MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2157-9024</gtr:issn><gtr:outcomeId>545b90fe358693.53589204</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F4735C6-D31D-4BA3-A77A-D0E3D6BBC5F5</gtr:id><gtr:title>ESTABLISHING AREAS OF CONSENSUS FOR THE MANAGEMENT OF INTRACRANIAL GERM CELL TUMOURS (ICGCTS) USING A MULTI-DISCIPLINARY DELPHI METHOD</gtr:title><gtr:parentPublicationTitle>NEURO-ONCOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63ab155173b9242519d9a3f78acc85db"><gtr:id>63ab155173b9242519d9a3f78acc85db</gtr:id><gtr:otherNames>Murray Matthew</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1522-8517</gtr:issn><gtr:outcomeId>56cc33ca139875.72077583</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE2A9021-B1F7-4051-BA69-4E83F7F881F2</gtr:id><gtr:title>Depletion of HPV16 early genes induces autophagy and senescence in a cervical carcinogenesis model, regardless of viral physical state.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4b93646eadd98ab3074e0bd2fb059d0b"><gtr:id>4b93646eadd98ab3074e0bd2fb059d0b</gtr:id><gtr:otherNames>Hanning JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>pm_16103_23_23913724</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E96AA9A-41B1-4633-B5CB-89CCF09C0E07</gtr:id><gtr:title>Testicular cancer: a new generation of biomarkers for malignant germ cell tumours.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Urology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98136b98a07f8ae33ef41569cbc66294"><gtr:id>98136b98a07f8ae33ef41569cbc66294</gtr:id><gtr:otherNames>Murray MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1759-4812</gtr:issn><gtr:outcomeId>pm_16103_23_22549310</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AB0496F-3010-44EA-AE78-6AF9EF568CF2</gtr:id><gtr:title>Germ cell tumours in children and adolescents</gtr:title><gtr:parentPublicationTitle>Paediatrics and Child Health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f6f0453a121999165934fdb45d5f7914"><gtr:id>f6f0453a121999165934fdb45d5f7914</gtr:id><gtr:otherNames>Murray M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>jq7srccnCh5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAD1E244-A905-4DFF-A297-C321F16AC7B5</gtr:id><gtr:title>Solid tumours of childhood display specific serum microRNA profiles</gtr:title><gtr:parentPublicationTitle>VIRCHOWS ARCHIV</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac5cab70b796d0545ecd113ae9cc8c46"><gtr:id>ac5cab70b796d0545ecd113ae9cc8c46</gtr:id><gtr:otherNames>Murray M. J.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0945-6317</gtr:issn><gtr:outcomeId>56cc334c00f773.53100403</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>747FFD54-62F8-4FDB-9D04-960B7EE281AE</gtr:id><gtr:title>SOLID TUMORS OF CHILDHOOD DISPLAY SPECIFIC SERUM MICRORNA PROFILES</gtr:title><gtr:parentPublicationTitle>PEDIATRIC BLOOD &amp; CANCER</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4eea61b314e322052be630a6bc3ebfee"><gtr:id>4eea61b314e322052be630a6bc3ebfee</gtr:id><gtr:otherNames>Murray M.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1545-5009</gtr:issn><gtr:outcomeId>56cc334c2e81e8.91325603</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1EB60EAD-3B56-48A5-9DAE-BF21FA95ECDC</gtr:id><gtr:title>Highlights from the Third International Central Nervous System Germ Cell Tumour symposium: laying the foundations for future consensus.</gtr:title><gtr:parentPublicationTitle>Ecancermedicalscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98136b98a07f8ae33ef41569cbc66294"><gtr:id>98136b98a07f8ae33ef41569cbc66294</gtr:id><gtr:otherNames>Murray MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1754-6605</gtr:issn><gtr:outcomeId>pm_16103_23_23861728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53B50906-B140-4E7F-BF6D-5FA082800F9C</gtr:id><gtr:title>Lack of correlation between predicted and actual off-target effects of short-interfering RNAs targeting the human papillomavirus type 16 E7 oncogene.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4b93646eadd98ab3074e0bd2fb059d0b"><gtr:id>4b93646eadd98ab3074e0bd2fb059d0b</gtr:id><gtr:otherNames>Hanning JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>pm_16103_23_23299538</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8B1F2E6-E341-42C9-9D04-14112A043E0B</gtr:id><gtr:title>The present and future of serum diagnostic tests for testicular germ cell tumours.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Urology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98136b98a07f8ae33ef41569cbc66294"><gtr:id>98136b98a07f8ae33ef41569cbc66294</gtr:id><gtr:otherNames>Murray MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1759-4812</gtr:issn><gtr:outcomeId>581b4780e4a741.61555848</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2255810F-7F73-48E5-98C7-4B85DEFB3D26</gtr:id><gtr:title>Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26f7007614bdad779c5fa7eaed91b3f7"><gtr:id>26f7007614bdad779c5fa7eaed91b3f7</gtr:id><gtr:otherNames>Palmer RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>Apny4UuKToi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8B99CA7-A350-4173-A7B1-FD8D8A228A88</gtr:id><gtr:title>Age-related biological features of germ cell tumors.</gtr:title><gtr:parentPublicationTitle>Genes, chromosomes &amp; cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6916cd5efb743794447ea2c257e650cb"><gtr:id>6916cd5efb743794447ea2c257e650cb</gtr:id><gtr:otherNames>Collinson K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1045-2257</gtr:issn><gtr:outcomeId>545b90cdc49280.77695555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4052F509-19B0-40D2-8323-0A40F46F99E2</gtr:id><gtr:title>Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4455576d3461d8066e8d04c4b6c2e5d"><gtr:id>f4455576d3461d8066e8d04c4b6c2e5d</gtr:id><gtr:otherNames>Muralidhar B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>UrSAKHxGu2X</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0C21B47-742C-4493-A390-CF15E7DAD80B</gtr:id><gtr:title>Identification of microRNAs From the miR-371~373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors.</gtr:title><gtr:parentPublicationTitle>American journal of clinical pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98136b98a07f8ae33ef41569cbc66294"><gtr:id>98136b98a07f8ae33ef41569cbc66294</gtr:id><gtr:otherNames>Murray MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-9173</gtr:issn><gtr:outcomeId>qhswQWfnPnb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F10D018-FD84-41B4-B85E-5391008B1435</gtr:id><gtr:title>The two most common histological subtypes of malignant germ cell tumour are distinguished by global microRNA profiles, associated with differential transcription factor expression.</gtr:title><gtr:parentPublicationTitle>Molecular cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98136b98a07f8ae33ef41569cbc66294"><gtr:id>98136b98a07f8ae33ef41569cbc66294</gtr:id><gtr:otherNames>Murray MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1476-4598</gtr:issn><gtr:outcomeId>J7HpSzU5THR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC1704FA-B383-4BC3-BB09-951C395C30A5</gtr:id><gtr:title>Consensus on the management of intracranial germ-cell tumours</gtr:title><gtr:parentPublicationTitle>LANCET ONCOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/372cfb8517528cfa5777645a371fa19f"><gtr:id>372cfb8517528cfa5777645a371fa19f</gtr:id><gtr:otherNames>Murray Matthew J.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1470-2045</gtr:issn><gtr:outcomeId>56cc33c9dec241.59383055</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91F2A78C-7A82-4D2C-97E4-C9E4261879CA</gtr:id><gtr:title>Serum microRNA screening for DICER1-associated pleuropulmonary blastoma.</gtr:title><gtr:parentPublicationTitle>Pediatric blood &amp; cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a9eb643892cf6d165a4a027d05161ce"><gtr:id>5a9eb643892cf6d165a4a027d05161ce</gtr:id><gtr:otherNames>Bailey S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1545-5009</gtr:issn><gtr:outcomeId>545b9133e2dd70.65153070</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F35F0CA-AD09-4A2A-BE47-FDFC539A554A</gtr:id><gtr:title>Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: a proof of principle.</gtr:title><gtr:parentPublicationTitle>Molecular oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcf0418ac54d0e6675f94d467483d81b"><gtr:id>bcf0418ac54d0e6675f94d467483d81b</gtr:id><gtr:otherNames>Gillis AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1574-7891</gtr:issn><gtr:outcomeId>doi_16103_013_08_002</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B447606-3E8E-47FF-A0CF-E79D38007590</gtr:id><gtr:title>Biology of childhood germ cell tumours, focussing on the significance of microRNAs.</gtr:title><gtr:parentPublicationTitle>Andrology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98136b98a07f8ae33ef41569cbc66294"><gtr:id>98136b98a07f8ae33ef41569cbc66294</gtr:id><gtr:otherNames>Murray MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2047-2919</gtr:issn><gtr:outcomeId>545b9155b3ef89.15389377</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04067DE6-A1E4-4255-A192-A59E2BAF5CF6</gtr:id><gtr:title>A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98136b98a07f8ae33ef41569cbc66294"><gtr:id>98136b98a07f8ae33ef41569cbc66294</gtr:id><gtr:otherNames>Murray MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>56cc33ff0a9d41.81991875</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A02595A2-CE18-4AA2-9B7B-01BC7ECAE677</gtr:id><gtr:title>a-Fetoprotein.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood. Education and practice edition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98136b98a07f8ae33ef41569cbc66294"><gtr:id>98136b98a07f8ae33ef41569cbc66294</gtr:id><gtr:otherNames>Murray MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1743-0585</gtr:issn><gtr:outcomeId>aGte2qXBTBz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43C0D3F7-89EE-4F3C-BA8E-D52A4F69205C</gtr:id><gtr:title>Biallelic somatic SMARCA4 mutations in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT).</gtr:title><gtr:parentPublicationTitle>Pediatric blood &amp; cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a9eb643892cf6d165a4a027d05161ce"><gtr:id>5a9eb643892cf6d165a4a027d05161ce</gtr:id><gtr:otherNames>Bailey S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1545-5009</gtr:issn><gtr:outcomeId>545b91748b1e72.01270577</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD6B89E5-5AEF-481F-816F-962CCB7C672D</gtr:id><gtr:title>&amp;quot;Future-Proofing&amp;quot; Blood Processing for Measurement of Circulating miRNAs in Samples from Biobanks and Prospective Clinical Trials.</gtr:title><gtr:parentPublicationTitle>Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98136b98a07f8ae33ef41569cbc66294"><gtr:id>98136b98a07f8ae33ef41569cbc66294</gtr:id><gtr:otherNames>Murray MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1055-9965</gtr:issn><gtr:outcomeId>5a9e5440d38224.76270967</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3ABF0854-FEF1-4585-A791-67E94AF7E4C0</gtr:id><gtr:title>Familial rhabdoid tumour 'avant la lettre'--from pathology review to exome sequencing and back again.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56d02bb6684d2d790194f9046ab151cf"><gtr:id>56d02bb6684d2d790194f9046ab151cf</gtr:id><gtr:otherNames>Witkowski L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>pm_16103_23_23775540</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D21CA7E-A711-47CC-8440-C100A0EBF2F4</gtr:id><gtr:title>Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistance.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/028fd847b82ed844018ff4568a3ecf41"><gtr:id>028fd847b82ed844018ff4568a3ecf41</gtr:id><gtr:otherNames>Jeyapalan JN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>VTmHUK3K7zR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F88EFA8B-69FC-42FA-8E7C-21D3B44F45AD</gtr:id><gtr:title>DICER1 hotspot mutations in non-epithelial gonadal tumours.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56d02bb6684d2d790194f9046ab151cf"><gtr:id>56d02bb6684d2d790194f9046ab151cf</gtr:id><gtr:otherNames>Witkowski L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>pm_16103_23_24136150</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1A4148A-97B0-4969-967C-5521D58B8117</gtr:id><gtr:title>Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98136b98a07f8ae33ef41569cbc66294"><gtr:id>98136b98a07f8ae33ef41569cbc66294</gtr:id><gtr:otherNames>Murray MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>5a9e55589203a5.70965264</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_EX_G0800464</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>